Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 22:33 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 4UnknownINTERVENTIONAL

Cetrorelix and Ganirelix Flexible Protocol for (IVF)

ClinicalTrials.gov · NCT03477929 · Registry updated: 2018-03-27

Condition / research focus: Infertility/Sterility
Sponsor: Università degli Studi 'G. d'Annunzio' Chieti e Pescara
Countries with listed sites: Italy
Registry dates and results: Start: 2017-11-15. Completion: 2019-01-15 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Ganirelix Acetate (drug)
Cetrorelix Acetate (drug)

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Ospedale Bernabeo
Ortona, Chieti, Italy
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

A Randomised, Phase II, Comparative Study With a Parallel Control for Evaluating the Efficacy and Safety of Combined Treatment of Lutropin Alpha and Recombinant Human Luteinizing Hormone in the Middle of the Controlled Ovarian Stimulation Follicular Phase in Women With Reduced Ovarian Reserve

ClinicalTrials.gov · NCT01110707 · Registry updated: 2018-03-27

Condition / research focus: Infertility; Ovulation Induction
Sponsor: Merck KGaA, Darmstadt, Germany
Countries with listed sites: Spain
Registry dates and results: Start: 2005-01-10. Completion: 2006-11-15 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Recombinant human follicle stimulating hormone (r-hFSH) (drug) — also listed as: GONAL-f, Follitrophin alpha
Recombinant human luteinizing hormone (r-hLH) (drug) — also listed as: Luveris, Lutrophin alpha

Where the study takes place — 1 listed sites

Hospital de Cruces, Plaza de Cruces, 12, 48903
Vizcaya, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

L-Carnitine and Clomiphene Citrate for Induction of Ovulation in Women With Polycystic Ovary Syndrome

ClinicalTrials.gov · NCT03476356 · Registry updated: 2018-03-26

Condition / research focus: Polycystic Ovary Syndrome
Sponsor: Ain Shams University
Countries with listed sites: Egypt
Registry dates and results: Start: 2017-11-01. Completion: 2018-03-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

oral clomiphene citrate (drug) — also listed as: clomid
oral carnitine supplementation (drug) — also listed as: Carnitiva Forte

Where the study takes place — 1 listed sites

Department of obstetrics and gynaecology, faculty of medicine, Ain shams university
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1UnknownINTERVENTIONAL

Effects of Pentoxifylline and Vitamin E on Pregnancy Rate in Infertile Women Treated by ICSI:

ClinicalTrials.gov · NCT03476564 · Registry updated: 2018-03-26

Condition / research focus: Infertility, Female
Sponsor: Benha University
Countries with listed sites: Egypt
Registry dates and results: Start: 2018-05-01. Completion: 2018-09-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

pentoxifylline (drug) — also listed as: Trental S.R. 400 mg/BD
Vit E (drug) — also listed as: Vit E PHARCO 400 mg/BD

Where the study takes place — 1 listed sites

El Galaa Teaching hosptial
Cairo, Ghamra, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Efficacy of Recombinant FSH/GnRH Antagonist Protocol With and Without LH Adjunct for Egg Bank Donation

ClinicalTrials.gov · NCT02069808 · Registry updated: 2018-03-23

Condition / research focus: Egg Donation
Sponsor: Michigan Reproductive Medicine
Countries with listed sites: United States
Registry dates and results: Start: 2014-04. Completion: 2017-03-08 (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Follistim (drug) — also listed as: Follistim AQ
Ganirelix (drug) — also listed as: Ganirelix Acetate
Menotropins (drug) — also listed as: Menopur
Leuprolide (drug) — also listed as: Lupron, Leuprolide acetate
Transvaginal ultrasound guided needle aspiration of oocytes (procedure)

Where the study takes place — 1 listed sites

Michigan Reproductive Medicine
Bloomfield Hills, Michigan, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Uterine Flushing With Human Chorionic Gonadotrophin and Unexplained Infertility

ClinicalTrials.gov · NCT03461601 · Registry updated: 2018-03-12

Condition / research focus: Unexplained Infertility
Sponsor: Ahmed Walid Anwar Murad
Countries with listed sites: No country reported
Registry dates and results: Start: 2014-06-01. Completion: 2017-06-01 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

HCG Uterine flushing (procedure)
IUI (procedure)
Vaginal flushing with 10 ml normal saline (procedure)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Implantation Enhancement by Elective Cryopreservation of All Viable Embryos

ClinicalTrials.gov · NCT02148393 · Registry updated: 2018-03-09

Condition / research focus: Infertility; OHSS
Sponsor: Universitair Ziekenhuis Brussel
Countries with listed sites: Belgium
Registry dates and results: Start: 2014-05. Completion: 2017-02-28 (may be estimated). No results posted in this registry response.

Products and interventions (6)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vitrification with subsequent-cycle embryo thawing/transfer (procedure)
Intensified luteal phase support for fresh embryo transfer (procedure)
Pregnyl® (drug) — also listed as: hCG
Utrogestan® (drug) — also listed as: Vaginal progesterone
Progynova® (drug) — also listed as: Estradiol valerate
CryoBioSystem® (device)

Where the study takes place — 1 listed sites

Universitair Ziekenhuis Brussel
Brussels, Lisboa, Belgium
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

The Impact of Body Weight on Reproductive Outcomes in Poor Ovarian Responders in ICSI Cycles

ClinicalTrials.gov · NCT03457233 · Registry updated: 2018-03-07

Condition / research focus: Invitro Fertilization
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-01-03. Completion: 2018-03 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Gonadotropins (drug) — also listed as: Human menopausal gonadotropin
GNRH antagonist (drug) — also listed as: cetrorelix
Human chorionic gonadotropin Chorimon (drug) — also listed as: HCG
Natural progesterone (drug) — also listed as: prontogest

Where the study takes place — 1 listed sites

Kasr Alainy medical school
Cairo, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Vaginal Progesterone Supplementation in Women With PCOS Undergoing Ovulation Induction With Letrozole

ClinicalTrials.gov · NCT03440359 · Registry updated: 2018-02-26

Condition / research focus: Polycystic Ovary Syndrome
Sponsor: Eastern Virginia Medical School
Countries with listed sites: United States
Registry dates and results: Start: 2012-07-06. Completion: 2017-12-30 (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Progesterone Vaginal Gel 8% (drug) — also listed as: Crinone 8% vaginal gel
Letrozole Oral Tablet (drug)
pelvic ultrasound (diagnostic_test)
Ovidrel 250 MCG Per 0.5 ML Prefilled Syringe (drug) — also listed as: recombinant hCG 250 mcg
Intrauterine insemination or timed intercourse (other)

Where the study takes place — 1 listed sites

Laurel A. Stadtmauer, MD, PhD
Norfolk, Virginia, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Effect of Low-frequency Electroacupuncture (EA) on Polycystic Ovary Syndrome

ClinicalTrials.gov · NCT01812161 · Registry updated: 2018-02-26

Condition / research focus: Polycystic Ovary Syndrome
Sponsor: Huazhong University of Science and Technology
Countries with listed sites: China
Registry dates and results: Start: 2012-11. Completion: 2017-09 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

acupuncture protocol 1 (other) — also listed as: real acupuncture
Acupuncture protocol 2 (other) — also listed as: sham acupuncture

Where the study takes place — 1 listed sites

Department of Integrated Traditional Chinese and Western Medicine Tongji hospital of Huazhong University of Science and Technology
Wuhan, Hubei, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Three Small Doses of HCG Versus Booster Dose of HCG on Ovum Pickup Day

ClinicalTrials.gov · NCT02397551 · Registry updated: 2018-01-29

Condition / research focus: Infertility
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-03. Completion: 2018-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

IVF/ICSI (procedure)
Human Chorionic Gonadotropin (drug)

Where the study takes place — 3 listed sites

IVF centre, Obstetrics and Gynaecology Department, Cairo University Hospitals (Kasr EL Aini)
Cairo, Egypt
Site recruitment: Not reported
Adam International hospital
Giza, Egypt
Site recruitment: Not reported
Nile IVF center
Giza, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Dual Trigger Versus Booster Dose of HCG

ClinicalTrials.gov · NCT02397642 · Registry updated: 2018-01-29

Condition / research focus: Infertility
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-03. Completion: 2018-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

IVF/ICSI (procedure)
Human Chorionic Gonadotropin (drug)

Where the study takes place — 3 listed sites

IVF centre, Obstetrics and Gynaecology Department, Cairo University Hospitals (Kasr EL Aini)
Cairo, Egypt
Site recruitment: Not reported
Adam International hospital
Giza, Egypt
Site recruitment: Not reported
Nile IVF center
Giza, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableNo longer availableEXPANDED ACCESS

Program for Pembrolizumab (MK-3475) in Participants With Metastatic Melanoma Who Have Failed Standard of Care Therapy Including Ipilimumab (MK-3475-030)

ClinicalTrials.gov · NCT02083484 · Registry updated: 2018-01-26

Condition / research focus: Melanoma
Sponsor: Merck Sharp & Dohme LLC
Countries with listed sites: No country reported
Registry dates and results: Start: Not reported. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Pembrolizumab (biological)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Intralipid for Recurrent Miscarriage

ClinicalTrials.gov · NCT01788540 · Registry updated: 2018-01-26

Condition / research focus: Abortion, Spontaneous; Abortion, Habitual
Sponsor: Woman's Health University Hospital, Egypt
Countries with listed sites: Egypt
Registry dates and results: Start: 2013-02. Completion: 2016-09 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intralipid (drug) — also listed as: intralipid 20%

Where the study takes place — 1 listed sites

Kasr el ainy hospital
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableWithdrawnINTERVENTIONAL

SO+IUI After Operative Laparoscopy in Patients With Advanced Stage Endometriosis

ClinicalTrials.gov · NCT02520505 · Registry updated: 2018-01-24

Condition / research focus: Endometriosis; Infertility
Sponsor: The Cleveland Clinic
Countries with listed sites: United States
Registry dates and results: Start: 2015-04. Completion: 2017-12 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Supraovulation clomiphene citrate (drug) — also listed as: Clomiphene citrate
Timed intercourse (behavioral) — also listed as: Expectant management
Intrauterine Insemination (procedure) — also listed as: IUI

Where the study takes place — 1 listed sites

Cleveland Clinic Foundation
Cleveland, Ohio, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Effect of Endometrial Injury in Couples With Unexplained Infertility

ClinicalTrials.gov · NCT03398993 · Registry updated: 2018-01-16

Condition / research focus: Unexplained Infertility
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2018-01. Completion: 2018-12 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Clomiphene Citrate (drug) — also listed as: clomid
Human chorionic gonadotropin (drug) — also listed as: MerionaL
Endometrial scratch (device)

Where the study takes place — 1 listed sites

Kasr Alainy medical school
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableNo longer availableEXPANDED ACCESS

Expanded Access for Pembrolizumab (MK-3475)

ClinicalTrials.gov · NCT03311542 · Registry updated: 2018-01-10

Condition / research focus: Melanoma (Skin); Melanoma Recurrent; Glioblastoma Multiforme; Glioblastoma by Gene Expression Profile; Glioma of Brain
Sponsor: Center Trials & Treatment
Countries with listed sites: Belarus · Hong Kong · Tajikistan · Uzbekistan
Registry dates and results: Start: Not reported. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

pembrolizumab (biological) — also listed as: MK-3475

Where the study takes place — 4 listed sites

N.N. Alexandrov National Cancer Centre
Minsk, Belarus
Site recruitment: Not reported
The Hong Kong Cancer Institute
Hong Kong, Hong Kong
Site recruitment: Not reported
"Cancer Research Center" of the Ministry of Health of the Republic of Tajikistan
Dushanbe, Tajikistan
Site recruitment: Not reported
Republican Cancer Research Center of the Ministry of Health of the Republic of Uzbekistan (RENTC MH RUz)
Tashkent, Uzbekistan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Combined Dehydropeiandrosterone and Growth Hormone in Women With Expected Poor Ovarian Response Undergoing ICSI

ClinicalTrials.gov · NCT02766764 · Registry updated: 2018-01-03

Condition / research focus: Subfertility
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2016-06. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

DHEA (drug)
Growth hormone (drug)
Placebo 1 (drug)
Placebo 2 (drug)

Where the study takes place — 2 listed sites

Cairo university hospitals
Cairo, Egypt
Site recruitment: Recruiting
Dar AlTeb subfertility centre
Cairo, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Endometrial Volume and Sub-endometrial Vascularity as Predictors of In-vitro Fertilization Success

ClinicalTrials.gov · NCT02381821 · Registry updated: 2018-01-03

Condition / research focus: Reproductive Techniques, Assisted
Sponsor: Cairo University
Countries with listed sites: No country reported
Registry dates and results: Start: 2016-01-01. Completion: 2017-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

3 D ultrasound and Doppler examination (other)
GnRH agonist (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Stimulated Versus Un-stimulated Intrauterine Insemination Cycles in Couples With Mild Male Factor Infertility

ClinicalTrials.gov · NCT02469805 · Registry updated: 2018-01-03

Condition / research focus: Subfertility
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-06. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Merional (drug)
Choriomon (drug)
IUI (procedure)
Ovulation detection (procedure)
Shepherd catheter (device)

Where the study takes place — 2 listed sites

BeniSuef University hospitals
BeniSuef, Egypt
Site recruitment: Recruiting
Cairo university hospitals
Cairo, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 22:33 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 4UnknownINTERVENTIONAL

Cetrorelix and Ganirelix Flexible Protocol for (IVF)

ClinicalTrials.gov · NCT03477929 · Registry updated: 2018-03-27

Condition / research focus: Infertility/Sterility
Sponsor: Università degli Studi 'G. d'Annunzio' Chieti e Pescara
Countries with listed sites: Italy
Registry dates and results: Start: 2017-11-15. Completion: 2019-01-15 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Ganirelix Acetate (drug)
Cetrorelix Acetate (drug)

Where the study takes place — 1 listed sites

Ospedale Bernabeo
Ortona, Chieti, Italy
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

A Randomised, Phase II, Comparative Study With a Parallel Control for Evaluating the Efficacy and Safety of Combined Treatment of Lutropin Alpha and Recombinant Human Luteinizing Hormone in the Middle of the Controlled Ovarian Stimulation Follicular Phase in Women With Reduced Ovarian Reserve

ClinicalTrials.gov · NCT01110707 · Registry updated: 2018-03-27

Condition / research focus: Infertility; Ovulation Induction
Sponsor: Merck KGaA, Darmstadt, Germany
Countries with listed sites: Spain
Registry dates and results: Start: 2005-01-10. Completion: 2006-11-15 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Recombinant human follicle stimulating hormone (r-hFSH) (drug) — also listed as: GONAL-f, Follitrophin alpha
Recombinant human luteinizing hormone (r-hLH) (drug) — also listed as: Luveris, Lutrophin alpha

Where the study takes place — 1 listed sites

Hospital de Cruces, Plaza de Cruces, 12, 48903
Vizcaya, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

L-Carnitine and Clomiphene Citrate for Induction of Ovulation in Women With Polycystic Ovary Syndrome

ClinicalTrials.gov · NCT03476356 · Registry updated: 2018-03-26

Condition / research focus: Polycystic Ovary Syndrome
Sponsor: Ain Shams University
Countries with listed sites: Egypt
Registry dates and results: Start: 2017-11-01. Completion: 2018-03-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

oral clomiphene citrate (drug) — also listed as: clomid
oral carnitine supplementation (drug) — also listed as: Carnitiva Forte

Where the study takes place — 1 listed sites

Department of obstetrics and gynaecology, faculty of medicine, Ain shams university
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1UnknownINTERVENTIONAL

Effects of Pentoxifylline and Vitamin E on Pregnancy Rate in Infertile Women Treated by ICSI:

ClinicalTrials.gov · NCT03476564 · Registry updated: 2018-03-26

Condition / research focus: Infertility, Female
Sponsor: Benha University
Countries with listed sites: Egypt
Registry dates and results: Start: 2018-05-01. Completion: 2018-09-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

pentoxifylline (drug) — also listed as: Trental S.R. 400 mg/BD
Vit E (drug) — also listed as: Vit E PHARCO 400 mg/BD

Where the study takes place — 1 listed sites

El Galaa Teaching hosptial
Cairo, Ghamra, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Efficacy of Recombinant FSH/GnRH Antagonist Protocol With and Without LH Adjunct for Egg Bank Donation

ClinicalTrials.gov · NCT02069808 · Registry updated: 2018-03-23

Condition / research focus: Egg Donation
Sponsor: Michigan Reproductive Medicine
Countries with listed sites: United States
Registry dates and results: Start: 2014-04. Completion: 2017-03-08 (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Follistim (drug) — also listed as: Follistim AQ
Ganirelix (drug) — also listed as: Ganirelix Acetate
Menotropins (drug) — also listed as: Menopur
Leuprolide (drug) — also listed as: Lupron, Leuprolide acetate
Transvaginal ultrasound guided needle aspiration of oocytes (procedure)

Where the study takes place — 1 listed sites

Michigan Reproductive Medicine
Bloomfield Hills, Michigan, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Uterine Flushing With Human Chorionic Gonadotrophin and Unexplained Infertility

ClinicalTrials.gov · NCT03461601 · Registry updated: 2018-03-12

Condition / research focus: Unexplained Infertility
Sponsor: Ahmed Walid Anwar Murad
Countries with listed sites: No country reported
Registry dates and results: Start: 2014-06-01. Completion: 2017-06-01 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

HCG Uterine flushing (procedure)
IUI (procedure)
Vaginal flushing with 10 ml normal saline (procedure)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Implantation Enhancement by Elective Cryopreservation of All Viable Embryos

ClinicalTrials.gov · NCT02148393 · Registry updated: 2018-03-09

Condition / research focus: Infertility; OHSS
Sponsor: Universitair Ziekenhuis Brussel
Countries with listed sites: Belgium
Registry dates and results: Start: 2014-05. Completion: 2017-02-28 (may be estimated). No results posted in this registry response.

Products and interventions (6)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vitrification with subsequent-cycle embryo thawing/transfer (procedure)
Intensified luteal phase support for fresh embryo transfer (procedure)
Pregnyl® (drug) — also listed as: hCG
Utrogestan® (drug) — also listed as: Vaginal progesterone
Progynova® (drug) — also listed as: Estradiol valerate
CryoBioSystem® (device)

Where the study takes place — 1 listed sites

Universitair Ziekenhuis Brussel
Brussels, Lisboa, Belgium
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

The Impact of Body Weight on Reproductive Outcomes in Poor Ovarian Responders in ICSI Cycles

ClinicalTrials.gov · NCT03457233 · Registry updated: 2018-03-07

Condition / research focus: Invitro Fertilization
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-01-03. Completion: 2018-03 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Gonadotropins (drug) — also listed as: Human menopausal gonadotropin
GNRH antagonist (drug) — also listed as: cetrorelix
Human chorionic gonadotropin Chorimon (drug) — also listed as: HCG
Natural progesterone (drug) — also listed as: prontogest

Where the study takes place — 1 listed sites

Kasr Alainy medical school
Cairo, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Vaginal Progesterone Supplementation in Women With PCOS Undergoing Ovulation Induction With Letrozole

ClinicalTrials.gov · NCT03440359 · Registry updated: 2018-02-26

Condition / research focus: Polycystic Ovary Syndrome
Sponsor: Eastern Virginia Medical School
Countries with listed sites: United States
Registry dates and results: Start: 2012-07-06. Completion: 2017-12-30 (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Progesterone Vaginal Gel 8% (drug) — also listed as: Crinone 8% vaginal gel
Letrozole Oral Tablet (drug)
pelvic ultrasound (diagnostic_test)
Ovidrel 250 MCG Per 0.5 ML Prefilled Syringe (drug) — also listed as: recombinant hCG 250 mcg
Intrauterine insemination or timed intercourse (other)

Where the study takes place — 1 listed sites

Laurel A. Stadtmauer, MD, PhD
Norfolk, Virginia, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Effect of Low-frequency Electroacupuncture (EA) on Polycystic Ovary Syndrome

ClinicalTrials.gov · NCT01812161 · Registry updated: 2018-02-26

Condition / research focus: Polycystic Ovary Syndrome
Sponsor: Huazhong University of Science and Technology
Countries with listed sites: China
Registry dates and results: Start: 2012-11. Completion: 2017-09 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

acupuncture protocol 1 (other) — also listed as: real acupuncture
Acupuncture protocol 2 (other) — also listed as: sham acupuncture

Where the study takes place — 1 listed sites

Department of Integrated Traditional Chinese and Western Medicine Tongji hospital of Huazhong University of Science and Technology
Wuhan, Hubei, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Three Small Doses of HCG Versus Booster Dose of HCG on Ovum Pickup Day

ClinicalTrials.gov · NCT02397551 · Registry updated: 2018-01-29

Condition / research focus: Infertility
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-03. Completion: 2018-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

IVF/ICSI (procedure)
Human Chorionic Gonadotropin (drug)

Where the study takes place — 3 listed sites

IVF centre, Obstetrics and Gynaecology Department, Cairo University Hospitals (Kasr EL Aini)
Cairo, Egypt
Site recruitment: Not reported
Adam International hospital
Giza, Egypt
Site recruitment: Not reported
Nile IVF center
Giza, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Dual Trigger Versus Booster Dose of HCG

ClinicalTrials.gov · NCT02397642 · Registry updated: 2018-01-29

Condition / research focus: Infertility
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-03. Completion: 2018-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

IVF/ICSI (procedure)
Human Chorionic Gonadotropin (drug)

Where the study takes place — 3 listed sites

IVF centre, Obstetrics and Gynaecology Department, Cairo University Hospitals (Kasr EL Aini)
Cairo, Egypt
Site recruitment: Not reported
Adam International hospital
Giza, Egypt
Site recruitment: Not reported
Nile IVF center
Giza, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableNo longer availableEXPANDED ACCESS

Program for Pembrolizumab (MK-3475) in Participants With Metastatic Melanoma Who Have Failed Standard of Care Therapy Including Ipilimumab (MK-3475-030)

ClinicalTrials.gov · NCT02083484 · Registry updated: 2018-01-26

Condition / research focus: Melanoma
Sponsor: Merck Sharp & Dohme LLC
Countries with listed sites: No country reported
Registry dates and results: Start: Not reported. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Pembrolizumab (biological)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Intralipid for Recurrent Miscarriage

ClinicalTrials.gov · NCT01788540 · Registry updated: 2018-01-26

Condition / research focus: Abortion, Spontaneous; Abortion, Habitual
Sponsor: Woman's Health University Hospital, Egypt
Countries with listed sites: Egypt
Registry dates and results: Start: 2013-02. Completion: 2016-09 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intralipid (drug) — also listed as: intralipid 20%

Where the study takes place — 1 listed sites

Kasr el ainy hospital
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableWithdrawnINTERVENTIONAL

SO+IUI After Operative Laparoscopy in Patients With Advanced Stage Endometriosis

ClinicalTrials.gov · NCT02520505 · Registry updated: 2018-01-24

Condition / research focus: Endometriosis; Infertility
Sponsor: The Cleveland Clinic
Countries with listed sites: United States
Registry dates and results: Start: 2015-04. Completion: 2017-12 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Supraovulation clomiphene citrate (drug) — also listed as: Clomiphene citrate
Timed intercourse (behavioral) — also listed as: Expectant management
Intrauterine Insemination (procedure) — also listed as: IUI

Where the study takes place — 1 listed sites

Cleveland Clinic Foundation
Cleveland, Ohio, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Effect of Endometrial Injury in Couples With Unexplained Infertility

ClinicalTrials.gov · NCT03398993 · Registry updated: 2018-01-16

Condition / research focus: Unexplained Infertility
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2018-01. Completion: 2018-12 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Clomiphene Citrate (drug) — also listed as: clomid
Human chorionic gonadotropin (drug) — also listed as: MerionaL
Endometrial scratch (device)

Where the study takes place — 1 listed sites

Kasr Alainy medical school
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableNo longer availableEXPANDED ACCESS

Expanded Access for Pembrolizumab (MK-3475)

ClinicalTrials.gov · NCT03311542 · Registry updated: 2018-01-10

Condition / research focus: Melanoma (Skin); Melanoma Recurrent; Glioblastoma Multiforme; Glioblastoma by Gene Expression Profile; Glioma of Brain
Sponsor: Center Trials & Treatment
Countries with listed sites: Belarus · Hong Kong · Tajikistan · Uzbekistan
Registry dates and results: Start: Not reported. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

pembrolizumab (biological) — also listed as: MK-3475

Where the study takes place — 4 listed sites

N.N. Alexandrov National Cancer Centre
Minsk, Belarus
Site recruitment: Not reported
The Hong Kong Cancer Institute
Hong Kong, Hong Kong
Site recruitment: Not reported
"Cancer Research Center" of the Ministry of Health of the Republic of Tajikistan
Dushanbe, Tajikistan
Site recruitment: Not reported
Republican Cancer Research Center of the Ministry of Health of the Republic of Uzbekistan (RENTC MH RUz)
Tashkent, Uzbekistan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Combined Dehydropeiandrosterone and Growth Hormone in Women With Expected Poor Ovarian Response Undergoing ICSI

ClinicalTrials.gov · NCT02766764 · Registry updated: 2018-01-03

Condition / research focus: Subfertility
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2016-06. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

DHEA (drug)
Growth hormone (drug)
Placebo 1 (drug)
Placebo 2 (drug)

Where the study takes place — 2 listed sites

Cairo university hospitals
Cairo, Egypt
Site recruitment: Recruiting
Dar AlTeb subfertility centre
Cairo, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Endometrial Volume and Sub-endometrial Vascularity as Predictors of In-vitro Fertilization Success

ClinicalTrials.gov · NCT02381821 · Registry updated: 2018-01-03

Condition / research focus: Reproductive Techniques, Assisted
Sponsor: Cairo University
Countries with listed sites: No country reported
Registry dates and results: Start: 2016-01-01. Completion: 2017-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

3 D ultrasound and Doppler examination (other)
GnRH agonist (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Stimulated Versus Un-stimulated Intrauterine Insemination Cycles in Couples With Mild Male Factor Infertility

ClinicalTrials.gov · NCT02469805 · Registry updated: 2018-01-03

Condition / research focus: Subfertility
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-06. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Merional (drug)
Choriomon (drug)
IUI (procedure)
Ovulation detection (procedure)
Shepherd catheter (device)

Where the study takes place — 2 listed sites

BeniSuef University hospitals
BeniSuef, Egypt
Site recruitment: Recruiting
Cairo university hospitals
Cairo, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →